Clinical Trial Update: Dual Therapy With Dabigatran/Ticagrelor Versus Dual Therapy With Dabigatran/Clopidogrel in ACS Patients With Indication for NOAC Undergoing PCI [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing dual therapy with dabigatran and ticagrelor versus dabigatran and clopidogrel in ACS patients needing NOAC undergoing PCI; current sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Artery Disease
• Myocardial Infarction
• Myocardial Ischemia

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• Dabigatran (Dabigatran etexilate)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Zuyderland Medisch Centrum | Conditions: Coronary Artery Disease, Myocardial Ischemia | Phase 4 | Status: UNKNOWN